Autres langues Arch Therapeutics, Inc.

Actions

ARTH

US03939W2089

Marché Fermé - OTC Markets Autres places de cotation 21:58:34 03/05/2024			Varia. 5j.	Varia. 1 janv.
0,925 ^USD	-8,42 %		-21,61 %	-87,22 %

20/02	Arch Therapeutics, Inc. annonce ses résultats pour le premier trimestre clos le 31 décembre 2023	CI
15/02	Arch Therapeutics, Inc. annonce ses résultats pour l'exercice clos le 30 septembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Arch Therapeutics : New Financial Obligation - Form 8-K	03/04
Arch Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	20/02
Arch Therapeutics, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	15/02
Arch Therapeutics : New Financial Obligation - Form 8-K	15/12
Arch Therapeutics Provides Year End Operational Update	09/11
Arch Therapeutics to Present AC5® Advanced Wound System at the 2023 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)	02/11
Arch Therapeutics, Inc. to Present AC5®? Advanced Wound System at the 2023 Symposium on Advanced Wound Care Fall Meeting (SAWC Fall)	02/11
Arch Therapeutics, Inc. Provides Commercialization Update on the First Product, AC5 Advanced Wound System	13/09/23
Arch Therapeutics Provides AC5® Commercialization Update	13/09/23
Arch Therapeutics Completes Financing as Bridge to Uplisting	08/09/23
Arch Therapeutics, Inc. announced that it has received $2.560063 million in funding	31/08/23
Arch Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	11/08/23
Arch Therapeutics, Inc. announced that it expects to receive $1.850001 million in funding	07/07/23
Arch Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23/05/23
Arch Therapeutics to Present AC5(R) Advanced Wound System At 2023 Symposium on Advanced Wound Care	25/04/23
Arch Therapeutics to Present AC5® Advanced Wound System at 2023 Symposium on Advanced Wound Care (“SAWC”)	25/04/23
Dedicated HCPCS Billing Code for Arch Therapeutics’ AC5® Advanced Wound System Now In Effect	05/04/23
Arch Therapeutics, Inc. Announces Dedicated HCPCS Billing Code for its Advanced Wound System Now in Effect	05/04/23
Arch Therapeutics : Material Agreement - Form 8-K	17/03/23
Arch Therapeutics' AC5(R) Advanced Wound System Receives Dedicated HCPCS Billing Code from the Centers for Medicare & Medicaid Services	09/03/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Arch Therapeutics, Inc.

Actions

ARTH

US03939W2089

Autres langues

Filtres